Trials / Sponsors / Ocera Therapeutics
Ocera Therapeutics
Industry · 7 registered clinical trials.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Completed | AST-120 Used to Treat Mild Hepatic Encephalopathy Mild Hepatic Encephalopathy | Phase 2 | 2009-03-01 |
| Terminated | Safety and Efficacy of AST-120 in Patients With GERD Who Continue to be Symptomatic on a Standard Dose of PPI Gastroesophageal Reflux Disease (GERD) | Phase 2 | 2007-10-01 |
| Completed | Safety and Efficacy of AST-120 Compared to Lactulose in Patients With Hepatic Encephalopathy Hepatic Encephalopathy | Phase 2 | 2007-09-01 |
| Completed | Safety and Efficacy of AST-120 in Patients With Non-Constipating Irritable Bowel Syndrome Irritable Bowel Syndrome | Phase 2 | 2007-08-01 |
| Terminated | Safety and Efficacy of AST-120 in the Treatment of Antibiotic-Refractory Pouchitis Pouchitis | Phase 2 | 2007-03-01 |
| Completed | Safety and Efficacy of AST-120 in the Treatment of Pouchitis Pouchitis | Phase 2 | 2007-02-01 |
| Completed | Safety and Efficacy of AST-120 in Mild to Moderate Crohn's Patients With Fistulas Inflammatory Bowel Disease, Intestinal Fistula | Phase 3 | 2006-03-01 |